Most Viewed Interferon Current Events | Interferon News
|
| Page
1 of
6 |
119 Results |
|
|
|
Sort By:
Relevance | Date |
Over-the-Counter Arthritis Drug Glucosamine Might Also Help Against MS
Glucosamine, the over-the counter natural product that has been touted to help with joint and cartilage problems associated with arthritis, may also provide some relief to individuals with multiple sclerosis (MS), a degenerative, nervous system disease with no known cure. view more (2005-11-29)
New hope for Hepatitis C research
The mystery surrounding Hepatitis C, a disease that affects millions of people worldwide, is one step closer to being solved. view more (2006-08-11)
Researchers have discovered a gene that can block the spread of HIV
A team of researchers at the University of Alberta, including a scientist at the University of Pennsylvania, have discovered a gene that is able to block HIV, and thought to in turn prevent the onset of AIDS. view more (2008-02-29)
Preliminary study shows promise for treatment of renal cell cancer
A new study suggests that sunitinib is a promising agent for treatment of metastatic renal cell cancer, currently a disease without highly effective treatment options. view more (2006-06-07)
Healthy human immune system cells can respond to HIV-1
AIDS patients' failure to clear HIV-1 might not be due to the inability of the human immune system to recognise the virus, as was previously thought. view more (2006-05-18)
A new pharmaceutical drug that halts progress of metastatic kidney cancer
Research has shown the efficacy of a pharmaceutical drug known as sunitinib which halts progress of metastatic kidney cancer. view more (2007-03-02)
Finding a cure for cancer: the holy grail of science
To find a cure for cancer, the modern-day plague of our society - is synonymous to finding the holy grail of science. view more (2006-11-22)
Study details hepatitis C ability to block immune system response
Hepatitis C virus (HCV) is a worldwide public health problem. The World Health Organization estimates that 170 million people worldwide are chronically infected and that between 3-4 million are newly infected annually. view more (2006-05-19)
Molecular 'on/off switch' controls immune defenses against viruses
Much like flipping a light switch, the hepatitis C virus turns on human immune defenses upon entering the body but also turns off those defenses by manipulating interaction of key cellular proteins, UT Southwestern Medical Center researchers have found. view more (2006-12-26)
Newfound roadblock to interferon effectiveness against malignant melanoma
Researchers have uncovered a significant contributing factor to interferon resistance of malignant melanoma cells. view more (2005-09-22)
Drug that battles resistance to leukemia pill Gleevec 'extremely effective' against cancer
An experimental therapy that battles drug resistance in Chronic Myeloid Leukemia (CML) has proved "extremely effective" in fighting cancer, giving patients for whom all conventional therapies have failed another option. view more (2006-06-15)
Targeted therapy shows significant benefits over standard treatment for advanced kidney cancer
According to a new study, the drug sunitinib malate (Sutent®) is more effective than the current standard cytokine treatment given as an initial therapy for patients with advanced kidney cancer, also known as metastatic renal cell carcinoma (mRCC). view more (2006-06-05)
Hepatitis C responds best to combo of ribavirin and interferon, study concludes
A combination of the drugs ribavirin and interferon is more effective in treating hepatitis C than using interferon alone, but it also increases the risk of side effects, according to a new systematic review of recent evidence. view more (2005-07-20)
New protein vital for immune response is found
A newly discovered protein not only is vital to the immune system's ability to fight off viral infections but also has been found in an unexpected location within the cell, causing researchers to rethink previous notions about the workings of the human immune system. view more (2005-08-26)
Monitoring the response to vaccination against melanoma
A new study published in PLoS Medicine this week describes a way to measure the immune response in people treated with an experimental vaccine to melanoma. view more (2005-09-20)
Engineered molecule amplifies body's immune response
By altering a molecule called Stat1, which is involved in cellular immune signaling, scientists have succeeded in making the molecule more responsive and thus more efficient. view more (2005-09-29)
Research team develops cancer-curing T-lymphocyte-based therapy to eradicate malignant tumours
Research in Immunology and Cancer (IRIC) of the Université de Montréal, has succeeded in developing a new approach to eradicate malignant melanoma tumours in mice. view more (2005-10-19)
Dual-drug therapy targets one colon cancer gene
Johns Hopkins Kimmel Cancer Center scientists have found that interferon, used for 30 years to treat blood cancers, multiple sclerosis and hepatitis, selectively kills colon cancer cells when combined with another standard chemotherapy agent. view more (2005-08-18)
A new step towards an AIDS vaccine
Progressive disease after HIV infection is inversely correlated with the presence of plasmacytoid dendritic cells (pDCs), a subset of the dendritic cell family and the major producers of type 1 interferon in the body. view more (2005-10-14)
New gene regulation mechanism discovered
Researchers at Cold Spring Harbor Laboratory have discovered a new kind of messenger RNA molecule that is converted from non-protein coding status to protein coding status in response to cellular stress such as viral infection. view more (2005-10-21)
|
|
| Page
1 of
6 |
119 Results |
|
|
|
Sort By:
Relevance | Date |
|
